Skip to Content

Asmanex Approval History

FDA Approved: Yes (First approved March 30, 2005)
Brand name: Asmanex
Generic name: mometasone furoate
Dosage form: Inhalation Powder
Company: Schering-Plough Corporation
Treatment for: Asthma

Asmanex Twisthaler (mometasone furoate) is an inhaled corticosteroid for the treatment of asthma.

Development History and FDA Approval Process for Asmanex

DateArticle
Feb  4, 2008Approval FDA Approves Asmanex Twisthaler (Mometasone Furoate InhalationPowder) for the Once Daily Maintenance Treatment of Asthma inChildren Ages 4-11
Mar 30, 2005Approval FDA Approves Asmanex Twisthaler for Asthma

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide